9:00 AM ET
8-K
Executive Compensation
PMV Pharmaceuticals Executive Compensation
PMV Pharmaceuticals appointed Dr. Matthew Eckler to its Board of Directors, effective October 1, 2026. Dr. Eckler will receive an annual cash retainer of $40,000 and was granted an initial stock option award for 84,000 shares under the company's Outside Director Compensation Policy. The appointment comes as the company prepares for a planned NDA submission for rezatapopt in early 2027.
- Counterparty
- Dr. Matthew Eckler
- Term
- through 2029 Annual Meeting